ImmunoBiochem

ImmunoBiochem is an innovative biopharmaceutical company with the mission to develop novel biotherapies to address significant unmet needs in the fields of oncology and immuno-oncology. ImmunoBiochem combines high-throughput functional screening, bioinformatics, and AI/ML to uncover unique biology within the tumor microenvironment, particularly the cancer cell secretome, and to discover new tumor targets that can be utilized across various targeted therapeutic modalities.